wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q26738509-3F0676B6-A9BB-40EA-A958-4E21D574AA30
Q26738509-3F0676B6-A9BB-40EA-A958-4E21D574AA30
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26738509-3F0676B6-A9BB-40EA-A958-4E21D574AA30
New developments in the treatment of chemotherapy-induced neutropenia: focus on balugrastim
P2860
Q26738509-3F0676B6-A9BB-40EA-A958-4E21D574AA30
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26738509-3F0676B6-A9BB-40EA-A958-4E21D574AA30
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
c80a59fa7d57371ae68dad5df0333b99907583ba
P2860
First-in-human, phase I/IIa dose-escalation and safety study of balugrastim in breast cancer patients receiving myelosuppressive chemotherapy.